Amedisys — Q3 2018 Earnings Presentation
21 slides from Amedisys's earnings presentation, Oct 29, 2018
Slide 1: Third Quarter 2018 Earnings Call Supplemental Slides
Amedisys Third Quarter 2018 Earnings Call Supplemental Slides October 30th, 2018 Exhibit 99.2
Slide 2: Forward-looking statements
This presentation may include forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a variety of risks and uncertainties that could cau
Slide 3: Our Key Areas of Focus
Our Key Areas of Focus Strategic areas of focus for 2018 and beyond Home Health*: Total same store volume +6%. Total same store admission +4% Hospice: Admissions +8%, ADC +11% Personal Care: Double digit growth in billable hours / quarter +32% (including acquisitions) 1 Organic Growth Quality: Amedi
Slide 4: Highlights and Summary Financial Results (Adjusted): 3Q 2018
Highlights and Summary Financial Results (Adjusted): 3Q 2018(1) Home Health total same store volume +6%, total same store admissions up +4%. Hospice same store admissions +8%. Personal Care +32% billable hours Amedisys Consolidated Revenue Growth: +10% EBITDA: $45M (+23%) EBITDA Margin: 11% EPS: $0.
Slide 5: Our revenue sources: 3Q18
Our revenue sources: 3Q18 Medicare FFS: Paid episodically over a 60 day episode Private Episodic: MA and Commercial plans who pay us over a 60 day episode. Generally at rates ~90% – 100% of Medicare Per Visit: Managed care, Medicaid and private payors reimbursing us per visit provided Hospice Per Da
Slide 6: Home Health and Hospice Segment (Adjusted) – 3Q 2018
Home Health and Hospice Segment (Adjusted) – 3Q 2018(1) Revenue per Episode up +$35 Recert rate up +120 bps CPV increase of 0.1% in Q3’18 EBITDA as a % percentage of revenue: +270bps Home Health Highlights Same store average daily census (ADC) up 11% Net revenue per day down 2.5% Two providers over
Slide 7: General & Administrative Expenses – Adjusted
General & Administrative Expenses – Adjusted (1,2) Notes: Year over year total G&A as a percentage of revenue decreased 120 basis points Home Health segment G&A: 230 bps decrease as % of revenue Hospice segment G&A: 90 bps increase as % of revenue Personal Care segment G&A: 610 bps decrease as % of
Slide 8: Industry Leading Quality Scores
Industry Leading Quality Scores Note: Top Competitor Avg weighted by CCN count and include LHC, Kindred, AFAM, HLS and BKD Metric JUL 18 OCT 18 PREVIEW JAN 19 PREVIEW Quality of Patient Care 4.38 4.41 4.40 Entities at 4+ Stars 93% 94% 94% Metric JAN 18 Release APR 18 Release JUL 18 Release Patient S
Slide 9: Hospice Quality: Amedisys Hospice Continues to Move Towards Best-in-Class Hospice Quality
Hospice Quality: Amedisys Hospice Continues to Move Towards Best-in-Class Hospice Quality
Slide 10: Cost per Visit Components
Components 3Q’17 2Q’18 3Q’18 YoY Variance Detail Mitigation Plan Salaries $61.65 $59.98 $61.93 $0.28 YoY increase due to planned wage increases offset by volume growth and increased productivity Staffing mix optimization, productivity and scheduling improvement initiatives in place helped us overcom
Slide 11: Driving Top Line Growth
Driving Top Line Growth All three lines of business continue to grow. Hospice delivers another quarter of double digit ADC growth and Home Health total same store volume continues to trend in the mid-single digits Home Health Total Same Store Volume* Hospice ADC Personal Care Total Hours / Quarter *
Slide 12: Compassionate Care Hospice acquisition overview
Overview Metrics Integration Timing Amedisys signs definitive agreement to acquire Compassionate Care Hospice 100% stock purchase Compassionate Care Hospice: Founded in 1993 100% founder owned Average Daily Census: 3,300 Revenue: $188M Adj. EBITDA: $27M Care Centers: 53 States: 24 Proforma for acqui
Slide 13: Debt and Liquidity Metrics
Debt and Liquidity Metrics Our debt levels remain very low at 0.3x net leverage Net debt defined as total debt outstanding ($59.8M) less cash balance ($14.0M). Leverage ratio (net) is defined as net debt divided by last twelve months adjusted EBITDA ($174M). Liquidity defined as the sum of cash bala
Slide 14: Cash Flow Statement Highlights
Cash Flow Statement Highlights (1) $64.7M in free cash flow for the quarter; $159M in cash flow from operations YTD 2018 Free cash flow defined as cash flow from operations less routine capital expenditures and required debt repayments.
Slide 15: Income Statement Adjustments
Income Statement Adjustments (1) Amount of non-GAAP adjustments remains low The financial results for the three-month periods ended September 30, 2017, December 31, 2017, March 31, 2018, June 30, 2018 and September 30, 2018 are adjusted for certain items and should be considered a non-GAAP financial
Slide 16: 2018 Guidance
2018 Guidance
Slide 17: 2018 Updated Guidance
2018 Updated Guidance (2Q) Amedisys Revised 2018 Guidance Increasing Revenue, Adjusted EBITDA and Adjusted EPS; EPS includes impact of tax reform and share repurchase 2017 Revenue Adjusted EBITDA $142.2M $1.54B - $1.52B* Adjusted Earnings per Share $2.21 $158M – $163M $1.60B – $1.64B $2.97 – $3.08 *
Slide 18: Amedisys 2018 Guidance Considerations
Amedisys 2018 Guidance Considerations Amedisys Consolidated Tax rate ~25% (includes impact from Tax Cuts and Jobs Act) Cash tax rate ~10% Diluted share count ~33.5 million shares Excludes potential acquisitions and related integration costs Capital Expenditures ~$7-$9 million Benefits increase ~5% -
Slide 19: Reimbursement Outlook
Reimbursement Outlook 2018 Reimbursement Impact for Home Health and Hospice Home Health Hospice 2018 Market Basket Update 1.0% Nominal Case Mix Adjustment -0.90 Estimated Industry Impact +0.1% Estimated AMED-Specific Impact -0.7% 2018 Market Basket Update 1.0% Productivity / Other Adjustment __ Esti
Slide 20: EBITDA Seasonality: As Reported
EBITDA Seasonality: As Reported Q1 Q2 Q3 Q4 Drivers of Seasonality Weather disruption Lower RPE (LUPA) Payroll tax reset Short Month (Feb.) Lower Hospice ADC & Higher Salary Cost per Day Highest Completed Episodes Stronger revenue per episode (RPE) Incremental holiday vs. 1H High PTO Lower Volumes H
Slide 21: EBITDA Seasonality: Excluding Health Insurance and Workers Compensation
EBITDA Seasonality: Excluding Health Insurance and Workers Compensation Q1 Q2 Q3 Q4 Drivers of Seasonality Weather disruption Lower RPE (LUPA) Payroll tax reset Short Month (Feb.) Lower Hospice ADC & Higher Salary Cost per Day Highest Completed Episodes Stronger revenue per episode (RPE) Incremental